Li X - Search Results

1

Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells.

Wang L, Qu J, Li J, Xue X, Qin L, Li Y, Dou Y, Mu X, Li X. Wang L, et al. Among authors: li y, li j, li x. Chin Med. 2024 Dec 31;19(1):179. doi: 10.1186/s13020-024-01038-1. Chin Med. 2024. PMID: 39741334 Free PMC article.

2

Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis.

Xue X, Wu J, Ding M, Gao F, Zhou F, Xu B, Lu M, Li J, Li X. Xue X, et al. Among authors: li j, li x. Chin Med. 2021 Nov 4;16(1):112. doi: 10.1186/s13020-021-00524-0. Chin Med. 2021. PMID: 34736501 Free PMC article.

3

Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition.

Qu J, Xue X, Wang Z, Ma Z, Jia K, Li F, Zhang Y, Wu R, Zhou F, Zhao P, Li X. Qu J, et al. Among authors: li f, li x. Chin J Nat Med. 2024 Jan;22(1):31-46. doi: 10.1016/S1875-5364(24)60560-1. Chin J Nat Med. 2024. PMID: 38278557

4

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice.

Xue X, Wang L, Wu R, Li Y, Liu R, Ma Z, Jia K, Zhang Y, Li X. Xue X, et al. Among authors: li y, li x. Chin Med. 2024 Jun 6;19(1):79. doi: 10.1186/s13020-024-00953-7. Chin Med. 2024. PMID: 38844978 Free PMC article.

5

Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment.

Ma Z, Xue X, Bai J, Cai Y, Jin X, Jia K, Ding M, Lyu X, Li X. Ma Z, et al. Among authors: li x. Biomed Pharmacother. 2022 Nov;155:113834. doi: 10.1016/j.biopha.2022.113834. Epub 2022 Oct 7. Biomed Pharmacother. 2022. PMID: 36271584 Free article.

6

Integrating systematic pharmacology-based strategy and experimental validation to explore mechanism of Tripterygium glycoside on cholangiocyte-related liver injury.

Li Y, Li S, Xue X, Wang T, Li X. Li Y, et al. Among authors: li s, li x. Chin Herb Med. 2022 Sep 27;14(4):563-575. doi: 10.1016/j.chmed.2022.02.006. eCollection 2022 Oct. Chin Herb Med. 2022. PMID: 36405068 Free PMC article.

7

LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.

Li XJ, Zhou F, Li YJ, Xue XY, Qu JR, Fan GF, Liu J, Sun R, Wu JZ, Zheng Q, Liu RP. Li XJ, et al. Acta Pharmacol Sin. 2023 Dec;44(12):2479-2491. doi: 10.1038/s41401-023-01145-z. Epub 2023 Aug 14. Acta Pharmacol Sin. 2023. PMID: 37580495 Free PMC article.

8

Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway.

Li Y, Li F, Ding M, Ma Z, Li S, Qu J, Li X. Li Y, et al. Among authors: li f, li s, li x. Chin Herb Med. 2023 Nov 28;16(1):82-93. doi: 10.1016/j.chmed.2023.07.003. eCollection 2024 Jan. Chin Herb Med. 2023. PMID: 38375042 Free PMC article.

9

Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA.

Ma Z, Xie K, Xue X, Li J, Yang Y, Wu J, Li Y, Li X. Ma Z, et al. Among authors: li y, li j, li x. J Ethnopharmacol. 2024 Jun 28;328:118057. doi: 10.1016/j.jep.2024.118057. Epub 2024 Mar 20. J Ethnopharmacol. 2024. PMID: 38518965

10

Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy.

Wu J, Gong L, Li Y, Qu J, Yang Y, Wu R, Fan G, Ding M, Xie K, Li F, Li X. Wu J, et al. Among authors: li f, li y, li x. J Ethnopharmacol. 2024 Oct 28;333:118456. doi: 10.1016/j.jep.2024.118456. Epub 2024 Jun 13. J Ethnopharmacol. 2024. PMID: 38878839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183,974 results

Search Page

Filters